- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 139
SandStone rocks series B-plus round
The data storage platform developer raised $21.4m in a round led by Cosco Shipping Development that will support recruitment and market expansion.
Jul 9, 2020Truepill fulfils $25m series B
Optum Ventures helped the prescription fulfilment platform push its total funding to more than $39m, with the cash to fund product development.
Jul 9, 2020VarmX arms itself with $36.2m series B
Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.
Jul 9, 2020VelosBio sells investors on $137m series B
The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.
Jul 9, 2020VarmX arms itself with series B cash
Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.
Jul 9, 2020Sayari strengthens series B round
The financial mapping software provider has added $2.5m to the SAP-backed first tranche it closed in January, taking the round to $11.5m.
Jul 8, 2020Vor gets more in $110m series B
Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.
Jul 8, 2020Vor leaps into $110m series B
Columbia University’s Vor Biopharma has collected more capital from shareholders including Osage University Partners, Johnson & Johnson and PureTech Health.
Jul 8, 2020Meituan Dianping puts $15m into Pudu
Delivery robot developer Pudu Robotics received a series B investment by the mobile services platform in connection with a strategic partnership.
Jul 7, 2020OxSonics sounds out $13.1m
The ultrasound therapeutics developer, a University of Oxford spinout, has raised series B2 funding in the run-up to clinical testing of its cancer drug delivery platform.
Jul 7, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


